Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
$367K Sell
1,398
-183
-12% -$49.1K 0.09% 167
2022
Q3
$356K Sell
1,581
-191
-11% -$46.3K 0.08% 157
2022
Q2
$431K Buy
1,772
+275
+18% +$67.4K 0.1% 154
2022
Q1
$362K Sell
1,497
-40
-3% -$9.19K 0.07% 179
2021
Q4
$346K Buy
+1,537
New +$324K 0.07% 169

Other funds holding AMGN

Titleist Capital's AMGN Position: Q4 2022 in Review

Titleist Capital reduced its Amgen (AMGN) stake by 12% in Q4 2022, selling an estimated $49.1K and leaving 1,398 shares worth $367K. The position accounts for 0.09% of the portfolio, ranked #167.

Titleist Capital first reported a position in AMGN in Q4 2021 and has held it in 5 quarters since. The position peaked at $431K in Q2 2022. 2,502 funds tracked by Wall St. Rank hold AMGN as of Q4 2022.

  • Titleist Capital held 1,398 shares of Amgen worth $367K as of Q4 2022.
  • Titleist Capital sold 183 Amgen shares in Q4 2022, an estimated $49.1K.
  • Amgen made up 0.09% of Titleist Capital's portfolio in Q4 2022, its #167 holding.
  • Titleist Capital first reported a position in Amgen in Q4 2021 and has held it in 5 quarters since.
  • Titleist Capital's Amgen position peaked at $431K in Q2 2022.
  • 2,502 funds tracked by Wall St. Rank held Amgen as of Q4 2022.

Based on Titleist Capital's 13F filing for Q4 2022, filed 12 Jan 2023.